SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S.